Only 35% of adult cancer survivors participate in clinical trials; older adults and minorities are even less likely to do so. Increased participation in cancer-related trials benefits society by helping to develop and test the safety of new cancer treatments, and benefits participants who receive high quality cancer care. This Public Health Live webcast will address psychosocial, financial and other barriers to recruitment into cancer clinical trials, highlight the disparities that exist in terms of participation and identify NYS resources and strategies which may help lower barriers and reduce disparities. Less